Most skin cancer is curable, especially when caught early. The two most common types, basal cell carcinoma and squamous cell carcinoma, have five-year survival rates near 100% and 90% respectively. Even melanoma, the most dangerous form, has a five-year survival rate of about 98% when it’s still confined to the skin.
What “Cured” Actually Means
In cancer medicine, “cured” means no traces of cancer remain after treatment and the cancer will never return. That’s a high bar, and most oncologists prefer the term “remission,” meaning all signs and symptoms have disappeared. If you stay in complete remission for five years or more, many doctors will start using the word “cured,” but with a caveat: some cancer cells can linger in the body for years, and a small number of cancers do return after that five-year mark.
For common skin cancers like basal cell carcinoma, this distinction is mostly academic. These cancers grow slowly, rarely spread, and surgery removes them with recurrence rates as low as 2 to 5%. In practical terms, the vast majority of people treated for basal cell or squamous cell carcinoma are cured.
Basal Cell and Squamous Cell Carcinoma
Basal cell carcinoma is the most common cancer in humans, and it’s also the most treatable. Population-based data show five-year relative survival rates close to 100%. It almost never spreads to other parts of the body. Squamous cell carcinoma is slightly more aggressive, with a five-year survival rate around 90% and a 10-year rate between 83 and 87%. Most squamous cell cancers are also cured with treatment, though a small percentage can spread to lymph nodes or distant organs if left untreated for too long.
The primary treatment for both types is surgical removal. Mohs micrographic surgery, where a surgeon removes tissue layer by layer and examines each one under a microscope before cutting further, has the lowest recurrence rate at about 2.1% after five years. Standard surgical excision has a recurrence rate around 3.5%, and a scraping-and-burning technique called electrodessication and curettage sits slightly higher at 4.9%.
For very superficial basal cell cancers, nonsurgical options exist. Prescription creams that stimulate the immune system can achieve complete clearance in clinical trials, particularly for surface-level tumors. Topical chemotherapy creams also work well for superficial basal cell carcinoma and precancerous spots, though recurrence rates tend to be higher than with surgery. These options are typically reserved for people who aren’t good candidates for surgery or whose tumors are in cosmetically sensitive areas.
Melanoma: Stage Makes All the Difference
Melanoma is the skin cancer most people worry about, and for good reason. It’s far more likely than other skin cancers to spread. But when it’s found early, the outlook is excellent. Localized melanoma, meaning the cancer hasn’t spread beyond the original site, has a five-year survival rate of 97.6%. Early-stage melanoma overall carries a five-year survival rate of about 94%.
The numbers shift dramatically once melanoma reaches nearby lymph nodes. At that regional stage, the five-year survival rate drops to 60.3%. This is why dermatologists emphasize monthly self-checks and annual skin exams. The difference between a thin melanoma removed in a 30-minute office procedure and one that has already reached the lymph nodes is enormous in terms of both treatment intensity and long-term survival.
For advanced melanoma that has spread to distant organs, the picture has improved significantly over the past decade. Immunotherapy drugs that help the immune system recognize and attack cancer cells have extended survival for many patients with stage IV disease. Some patients on these treatments achieve durable remissions lasting years, though advanced melanoma remains difficult to cure completely.
Why Early Detection Changes Everything
Across all skin cancer types, the single biggest factor in curability is how early the cancer is found. A basal cell carcinoma caught at a centimeter in size is a minor procedure. A squamous cell carcinoma that has been growing unnoticed for years and invaded deeper tissues becomes a more complex surgical case with a higher chance of recurrence. A melanoma thinner than a millimeter is almost always curable. One that has grown several millimeters deep may have already sent cells into the bloodstream.
You can catch skin cancers early by paying attention to changes on your skin. New spots that look different from your other moles, existing moles that change in size, shape, or color, sores that don’t heal within a few weeks, and any spot that bleeds, crusts, or itches persistently all warrant a closer look. People with fair skin, a history of sunburns, or a family history of melanoma face higher risk and benefit from more frequent professional skin exams.
After Treatment: What Follow-Up Looks Like
Even after successful treatment, skin cancer requires ongoing monitoring. The standard recommendation is a full-body skin exam every 6 to 12 months for the first five years, then at least once a year for life. This schedule exists for two reasons. First, treated skin cancers can occasionally recur at the original site. Second, and perhaps more importantly, having one skin cancer significantly raises your risk of developing another one. A history of basal cell carcinoma increases your risk for squamous cell carcinoma and melanoma as well.
Most recurrences happen within the first two years after treatment. If your skin stays clear for five years, the chance of that particular cancer returning drops substantially. But the lifelong monitoring reflects the reality that your skin has shown it’s susceptible to sun damage, and new cancers can develop at entirely different spots on your body for the rest of your life. Regular checks make it possible to catch any new cancers just as early as the first one.